2′-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression

Gut microbiota dysbiosis, together with goblet cells dysfunction has been observed in ulcerative colitis cases. This study aims to evaluate the potential of 2′-fucosyllactose (2′-FL) supplementation in inhibiting intestinal inflammation through regulating gut microbiota, protecting goblet cells, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Qianqian, Fan, Linlin, Zheng, Nan, Blecker, Christophe, Delcenserie, Véronique, Li, Huiying, Wang, Jiaqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892212/
https://www.ncbi.nlm.nih.gov/pubmed/35252301
http://dx.doi.org/10.3389/fnut.2022.822020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892212/
https://www.ncbi.nlm.nih.gov/pubmed/35252301
http://dx.doi.org/10.3389/fnut.2022.822020

Ejemplares similares